Identification of purine biosynthesis as an NADH-sensing pathway to mediate energy stress

An enhanced NADH/NAD(+) ratio, termed reductive stress, is associated with many diseases. However, whether a downstream sensing pathway exists to mediate pathogenic outcomes remains unclear. Here, we generate a soluble pyridine nucleotide transhydrogenase from Escherichia coli (EcSTH), which can elevate the NADH/NAD(+) ratio and meantime reduce the NADPH/NADP(+) ratio. Additionally, we fuse EcSTH with previously described LbNOX (a water-forming NADH oxidase from Lactobacillus brevis) to resume the NADH/NAD(+) ratio. With these tools and by using genome-wide CRISPR/Cas9 library screens and metabolic profiling in mammalian cells, we find that accumulated NADH deregulates PRPS2 (Ribose-phosphate pyrophosphokinase 2)-mediated downstream purine biosynthesis to provoke massive energy consumption, and therefore, the induction of energy stress. Blocking purine biosynthesis prevents NADH accumulation-associated cell death in vitro and tissue injury in vivo. These results underscore the pathophysiological role of deregulated purine biosynthesis in NADH accumulation-associated disorders and demonstrate the utility of EcSTH in manipulating NADH/NAD(+) and NADPH/NADP(+). Reductive stress, reflected by the elevated intracellular NADH/NAD(+) ratio, is associated with multiple human diseases. Here, the authors develop a genetic tool to manipulate the ratios of cellular NADH/NAD(+) and NADPH/NADP(+), and identify purine biosynthesis as an NADH-sensing pathway to mediate reductive stress.

Automated summary

This study reveals the pathophysiological role of deregulated purine biosynthesis in NADH accumulation-associated disorders and demonstrates the utility of manipulating NADH/NAD(+) and NADPH/NADP(+) using genetic tools. The authors develop a genetic tool to manipulate the ratios of cellular NADH/NAD(+) and NADPH/NADP(+), and identify purine biosynthesis as an NADH-sensing pathway to mediate reductive stress.